OrbiMed Capital GP IV LLC, 10% Owner at INTERCEPT PHARMACEUTICALS INC (ICPT), bought 2,150,634 shares at $15.00 ($5.0M) on 2012-10-16, disclosed to the SEC on 2012-10-16.
Open-market purchase of $5.0M ICPT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,817,300 | $0 | 0.0% |
| 2 | $15.00 | 333,334 | $5.0M | 100.0% |
| Total | $2.32 avg | 2,150,634 | $5.0M | 100% |
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |